Paul G. Marshall
Overview
Paul G. Marshall received an average of $2M in total compensation, including $287K in salary, at Heron Therapeutics from 2013 to 2015.
Source: SEC filing on April 29, 2016.
Related executives
We found 19 more executives who work or worked at Heron Therapeutics.
Kimberly Manhard
Heron Therapeutics
Executive Vice President, Drug Development
David Szekeres
Heron Therapeutics
Executive Vice President, Chief Commercial Officer
Barry Quart
Heron Therapeutics
Chief Executive Officer
John Poyhonen
Heron Therapeutics
President and Chief Commercial Officer
Lisa Peraza
Heron Therapeutics
Chief Accounting Officer
Robert Hoffman
Heron Therapeutics
Chief Financial Officer
Robert Rosen
Heron Therapeutics
Former President
Neil Clendeninn
Heron Therapeutics